The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

FRX Insider Trading (Fennec Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$6,499.94
Insider Selling (Last 12 Months): C$0.00

Fennec Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Fennec Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fennec Pharmaceuticals Share Price & Price History

Current Price: C$8.79
Price Change: Price Increase of +0.12 (1.38%)
As of 08/11/2022 01:00 AM ET

This chart shows the closing price history over time for FRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

Fennec Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Chris Anigeron RallisDirectorBuy11,111C$0.59C$6,499.9432,036
8/17/2020Robert Christopher AndradeSenior OfficerSell12,874C$7.99C$102,914.76158,273
8/17/2020Rostislav Christov RaykovDirectorSell12,093C$7.99C$96,671.442,355,838
8/13/2020Robert Christopher AndradeSenior OfficerSell97,136C$8.64C$839,060.77248,875
8/13/2020Rostislav Christov RaykovDirectorBuy323,961C$1.85C$599,327.852,541,011
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (TSE:FRX)

Fennec Pharmaceuticals logo
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Read More on Fennec Pharmaceuticals

Today's Range

Now: C$8.79
Low: C$8.79
High: C$8.79

50 Day Range

MA: C$8.04
Low: C$6.88
High: C$8.95

52 Week Range

Now: C$8.79
Low: C$4.95
High: C$13.25

Volume

100 shs

Average Volume

622 shs

Market Capitalization

C$228.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?

Fennec Pharmaceuticals' top insider shareholders include:
  1. Rostislav Christov Raykov (Director)
  2. Robert Christopher Andrade (Senior Officer)
  3. Chris Anigeron Rallis (Director)
Learn More about top insider investors at Fennec Pharmaceuticals.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.